Manipal Health Enterprises plans to utilise ₹5,552.7 crore from the fresh issue to repay debt, primarily borrowings raised for the acquisition of Sahyadri Hospitals. Another ₹574 crore will be used to acquire the remaining 9.84% stake in Sahyadri Hospitals. As…
This rotation out of chip stocks was also evident as investors chose to buy the beaten down software stocks, as shares of Accenture and Cognizant gained 7% each, while those of Salesforce and Adobe were also up 4.5% each. The…
Wipro and Oracle Financial are the underperformers of the month with gains of 6% each. Oracle Financial though, continues to remain the best performing IT stock on a year-to-date basis, with a 45% advance, while Coforge and Tech Mahindra also…
Manipal Health Enterprises has secured strong institutional backing ahead of its public issue, raising ₹4,167 crore from anchor investors at the upper end of its IPO price band. The hospital chain plans to use a significant portion of the fresh…
The U.S. Federal Reserve convenes today, July 28, for its two-day Federal Open Market Committee (FOMC) monetary policy meeting. Central bankers are gathering to evaluate sticky inflation data, steadying employment numbers, and volatile global energy dynamics before announcing their benchmark…
Shares of Graphite India Ltd ended at ₹648.10, down by ₹15.00, or 2.26%, on the BSE.
After conquering India’s skies, the airline is betting its next 20 years on global expansion. In his annual letter, IndiGo’s Managing Director Rahul Bhatia outlines ambitious overseas plans, reflects on last year’s disruptions and warns that geopolitical tensions and volatile…
The Nifty snapped its momentum on Tuesday, ending little changed after spending the monthly expiry session in a tight trading range. Weak global markets capped gains, while traders awaited fresh triggers to determine the index’s next move.
Indian markets are likely to take cues from a host of global and domestic events on Wednesday. The biggest trigger will be the US Federal Reserve’s interest rate decision, followed by Fed Chair Kevin Warsh’s press conference, which investors will…
Sanofi Consumer Healthcare India reported a 13.3% rise in second-quarter net profit, driven by higher domestic sales and a sharp improvement in operating margins, with EBITDA margin expanding to 37.9% from 31.8% a year ago.